Basic Information
Ignite Immunotherapy is committed to unleashing the full potential of cancer immunotherapy. Their optimized intravenous oncolytic cancer vaccine aims to complement approved immune checkpoint inhibitors by stimulating an immune response against patients' cancer. Their goal is to cure cancer patients through combination immunotherapy and intravenous oncolytic vaccines.
Ignite Immunotherapy Inc.
California,United States of America
less than 15 people
January 01, 2016
--
info@igniteimmunotherapy.com

